GE HealthCare Technologies Inc. $GEHC Holdings Raised by Plato Investment Management Ltd

Plato Investment Management Ltd grew its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 286.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,921 shares of the company’s stock after acquiring an additional 6,612 shares during the quarter. Plato Investment Management Ltd’s holdings in GE HealthCare Technologies were worth $658,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also made changes to their positions in GEHC. JPMorgan Chase & Co. grew its stake in GE HealthCare Technologies by 49.9% during the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock worth $414,894,000 after buying an additional 1,711,963 shares during the last quarter. Nuveen LLC bought a new position in GE HealthCare Technologies during the 1st quarter worth $77,058,000. Eminence Capital LP grew its stake in GE HealthCare Technologies by 38.7% during the 1st quarter. Eminence Capital LP now owns 1,819,129 shares of the company’s stock worth $146,822,000 after buying an additional 507,101 shares during the last quarter. Homestead Advisers Corp grew its stake in GE HealthCare Technologies by 92.7% during the 1st quarter. Homestead Advisers Corp now owns 988,600 shares of the company’s stock worth $79,790,000 after buying an additional 475,500 shares during the last quarter. Finally, Canada Pension Plan Investment Board grew its stake in GE HealthCare Technologies by 15.2% during the 1st quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock worth $251,121,000 after buying an additional 409,636 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Trading Down 0.1%

Shares of GEHC stock opened at $74.95 on Monday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80. The stock has a fifty day moving average of $75.09 and a two-hundred day moving average of $73.14. The firm has a market capitalization of $34.14 billion, a PE ratio of 15.49, a price-to-earnings-growth ratio of 2.82 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The company had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.07 billion. During the same quarter in the previous year, the firm posted $1.14 EPS. The firm’s quarterly revenue was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be given a $0.035 dividend. The ex-dividend date is Friday, October 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is 2.89%.

Analyst Ratings Changes

GEHC has been the subject of a number of recent research reports. Zacks Research downgraded GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. Evercore ISI upped their price objective on GE HealthCare Technologies from $88.00 to $92.00 and gave the stock an “outperform” rating in a research note on Thursday. Wells Fargo & Company lowered their price objective on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a research note on Thursday. Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Finally, Barclays initiated coverage on GE HealthCare Technologies in a research report on Monday, October 13th. They set an “equal weight” rating and a $86.00 price target for the company. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and an average price target of $86.10.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.